| 1 | Study | 1.58% | |
| 2 | Health | 1.19% | |
| 3 | Cancer | 1.13% | |
| 4 | New | 0.96% | |
| 5 | Risk | 0.9% | |
| 6 | Treatment | 0.85% | |
| 7 | May | 0.85% | |
| 8 | Disease | 0.85% | |
| 9 | Research | 0.73% | |
| 10 | Heart | 0.73% | |
| 11 | Brain | 0.68% | |
| 12 | Women | 0.51% | |
| 13 | Australia | 0.45% | |
| 14 | News | 0.45% | |
| 15 | COVID-19 | 0.4% | |
| 16 | Malaria | 0.4% | |
| 17 | Day | 0.4% | |
| 18 | Childhood | 0.4% | |
| 19 | Treatments | 0.34% | |
| 20 | Therapy | 0.34% | |
| 21 | AI | 0.34% | |
| 22 | NSW | 0.34% | |
| 23 | Boost | 0.34% | |
| 24 | National | 0.34% | |
| 25 | Patients | 0.34% | |
| 26 | Global | 0.34% | |
| 27 | Rare | 0.34% | |
| 28 | COVID | 0.34% | |
| 29 | RSV | 0.34% | |
| 30 | High | 0.28% | |
| 31 | Covid | 0.28% | |
| 32 | Cells | 0.28% | |
| 33 | Tumors | 0.28% | |
| 34 | Bacteria | 0.28% | |
| 35 | Severe | 0.28% | |
| 36 | US | 0.28% | |
| 37 | HIV | 0.28% | |
| 38 | Genetic | 0.28% | |
| 39 | Early | 0.28% | |
| 40 | Key | 0.28% | |
| 41 | MS | 0.28% | |
| 42 | Dementia | 0.28% | |
| 43 | Ozempic | 0.28% | |
| 44 | Alzheimers | 0.28% | |
| 45 | Could | 0.28% | |
| 46 | Gene | 0.28% | |
| 47 | Drug | 0.28% | |
| 48 | Weight | 0.23% | |
| 49 | Flu | 0.23% | |
| 50 | England | 0.23% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Cancer history raises cardiovascular disease risk in hypertensive patients - News
Medical.Net
2024-04-26 08:50:00
African campaigner calls for targeted interventions to eliminate malaria
China.org
2024-04-26 02:18:15
Creating Mice With Hybrid Rat Brains for Enhanced Sensory Abilities
Technology Networks
2024-04-26 00:48:33
The 3 Snacks a Celebrity Trainer Swears By for a Pre-Workout Energy Boost
EatingWell
2024-04-25 04:05:49
‘I can’t really explain it’: Ozempic works, so why is writer Johann Hari conflicted?
Sydney Morning Herald
2024-04-25 04:00:00
Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
The National Tribune
2024-04-25 01:02:09
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
The National Tribune
2024-04-24 22:12:19